NYSE:MLSS Milestone Scientific (MLSS) Stock Price, News & Analysis $0.31 +0.02 (+5.86%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$0.30 -0.01 (-2.61%) As of 11/13/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Milestone Scientific Stock (NYSE:MLSS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Milestone Scientific alerts:Sign Up Key Stats Today's Range$0.29▼$0.3250-Day Range$0.29▼$0.4752-Week Range$0.22▼$0.58Volume146,277 shsAverage Volume721,141 shsMarket Capitalization$27.83 millionP/E RatioN/ADividend YieldN/APrice Target$1.00Consensus RatingBuy Company Overview Milestone Scientific develops and commercializes computer-controlled drug-delivery instruments for dental and medical applications. Its technology is designed to regulate the flow and pressure of injections, with the aim of improving control and reducing discomfort during procedures. In dentistry, the company offers systems including the STA Single Tooth Anesthesia System and CompuDent, which are used to deliver local anesthetic. Its medical products include the CompuFlo system, designed for applications such as epidural injections and other procedures involving controlled drug delivery. Milestone Scientific sells its products in the United States and internationally through sales and distribution channels. The company has focused on expanding the use of its injection technology beyond dentistry into broader medical and pain-management settings.AI Generated. May Contain Errors. Read More Milestone Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScoreMLSS MarketRank™: 1.805355033465 of 5 starsMilestone Scientific scored higher than 36% of companies evaluated by MarketBeat, and ranked 726th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingMilestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.Upside PotentialMilestone Scientific has a consensus price target of $1.00, representing about 225.7% upside from its current price of $0.31.Amount of Analyst CoverageMilestone Scientific has only been the subject of 1 research reports in the past 90 days.Read more about Milestone Scientific's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Milestone Scientific is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Milestone Scientific is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMilestone Scientific has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for MLSS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMilestone Scientific does not currently pay a dividend.Dividend GrowthMilestone Scientific does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.38 News SentimentMilestone Scientific has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Milestone Scientific this week, compared to 1 article on an average week. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Milestone Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders9.22% of the stock of Milestone Scientific is held by insiders.Percentage Held by Institutions5.79% of the stock of Milestone Scientific is held by institutions.Read more about Milestone Scientific's insider trading history. Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLSS Stock News HeadlinesTranscript : Milestone Scientific Inc., Q3 2026 Earnings Call, Nov 13, 2026November 13 at 7:01 PM | marketscreener.comMMilestone Scientific (MLSS) Q3 2026 Earnings Call TranscriptNovember 13 at 7:01 PM | finance.yahoo.comUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 15 at 1:00 AM | Digest Publishing (Ad)Milestone Scientific Reports Financial Results for Third Quarter 2026November 13 at 7:30 AM | globenewswire.comEarnings To Watch: Milestone Scientific Inc (MLSS) Q3 2026 -- GF Value Sees 113% UpsideNovember 12 at 9:16 AM | finance.yahoo.comCORRECTION: Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference CallNovember 11, 2026 | globenewswire.comMilestone Scientific Inc. to Hold Conference Call on Third Quarter 2026 Financial Results and Corporate ProgressNovember 11, 2026 | quiverquant.comQMilestone Scientific Schedules Third Quarter 2026 Financial Results Conference CallNovember 11, 2026 | globenewswire.comSee More Headlines MLSS Stock Analysis - Frequently Asked Questions How have MLSS shares performed this year? Milestone Scientific's stock was trading at $0.2730 on January 1st, 2026. Since then, MLSS shares have increased by 12.5% and is now trading at $0.3070. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) posted its quarterly earnings results on Thursday, August, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The firm had revenue of $1.85 million for the quarter. Milestone Scientific had a negative net margin of 52.01% and a negative trailing twelve-month return on equity of 60.26%. Who are Milestone Scientific's major shareholders? Milestone Scientific's top institutional investors include State Street Corp (0.29%), NFSG Corp (0.24%) and Empowered Funds LLC (0.11%). Insiders that own company stock include SRL Bp4, Leonard Osser and Michael Mcgeehan. View institutional ownership trends. How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include BIOLASE (BIOL), ChronoScale Corporation Common Stock (CHRN), Clearside Biomedical (CLSD), Citius Pharmaceuticals (CTXR), CohBar (CWBR), Cyclacel Pharmaceuticals (CYCC) and Fortress Biotech (FBIO). Company Calendar Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 MLSS's financial health is in the Yellow zone, according to TradeSmith. MLSS has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:MLSS CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees15Year Founded1989Price Target and Rating Average Price Target for Milestone Scientific$1.00 High Price Target$1.00 Low Price Target$1.00 Potential Upside/Downside+225.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.93 million Net Margins-52.01% Pretax Margin-52.21% Return on Equity-60.26% Return on Assets-40.23% Debt Debt-to-Equity RatioN/A Current Ratio2.85 Quick Ratio1.86 Sales & Book Value Annual Sales$9.42 million Price / Sales2.95 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book2.79Miscellaneous Outstanding Shares90,644,000Free Float58,614,000Market Cap$27.83 million OptionableOptionable Beta1.14 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:MLSS) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.